"A lot of things went through my head at the time, I was thinking brain tumor, brain cancer, multiple sclerosis," Smith said. "Narcolepsy was the furthest thing from my mind."
Within a year after her diagnosis, Smith left her career.
"Untreated, even crossing the street is a challenge," Smith said. "If the light changes to yellow, you worry, 'Am I going to get across?,' and that can cause cataplexy."
Drugs helped, but Smith decided to stop using the high doses of antidepressants that mitigate the narcolepsy symptoms when she got pregnant with her second child. Even today, the drug treatments for narcoleptics are rife with side effects.
"It's brute force. It's hitting them over the head with medicine to manage it," said David Carley, Medicine and Pharmacology director at the Center for Narcolepsy, Sleep and Health Research at the University of Illinois at Chicago.
"Basically we're at the point of saying, 'OK, I know you tend to fall asleep. I'm going to overcome that by just bulldozing your central nervous system,'" Carley said.
Narcolepsy specialists borrow drugs made for other medical conditions that happen to take over the body's sleep cues, Carley said. With narcolepsy, the person doesn't sleep more, but just sporadically and suddenly.
Animal testing has started to explain aspects of narcolepsy, but even with treatment, many patients still suffer from debilitating exhaustion trying to fit with society's work days.
"In humans it's not a genetic mutation that causes narcolepsy," said Mignot, the director of the Center for Narcolepsy at Stanford. "It's an autoimmune response."
Narcolepsy researchers, actually at Mignot's lab, discovered the immune response explanation only eight years ago. They found that, somehow, the body was destroying nerve cells in the brain responsible for creating a chemical called hypocretin involved in sleep. By the time someone develops narcolepsy symptoms, 90 percent of the nerve cells n their brain that can create hypocretin are gone.
"But we still don't it understand it very well," Mignot said. "That's why it's very important to look for all the genes, so we know how these genes are involved in the immune response."
While the new genetic link to narcolepsy may help doctors to understand how the disorder develops, and therefore make better drugs to treat it, researchers do not expect that it will help diagnose patients -- and diagnosis is a serious problem.
"A lot of the past clinical studies suggest that it's about six to seven years from the onset of symptoms to an actual diagnosis," said Dr. James Herdegen, medical director of the Sleep Science Center at the University of Illinois at Chicago.
During those six to seven years, Smith said many patients slowly lose control of their life, their jobs and their families.
"Without treatment, I would be confined to my house," she said. "I could not do anything or commit to anything at a particular time. I could accomplish things but not on anybody's schedule but my own."
"As a mother, it's a challenge to care for your children if you're not treated," said Smith.
While she is waiting for better treatment and early diagnosis for others with narcolepsy, Smith hopes to raise awareness in the public.